INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 24 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $152,520 | -63.9% | 155,000 | -65.5% | 0.00% | – |
Q2 2023 | $422,509 | +56.5% | 449,000 | +50.2% | 0.00% | – |
Q1 2023 | $269,997 | +158.5% | 299,000 | +167.0% | 0.00% | – |
Q4 2022 | $104,440 | -89.0% | 112,000 | -88.5% | 0.00% | -100.0% |
Q3 2022 | $946,000 | -4.8% | 977,000 | -8.6% | 0.00% | 0.0% |
Q2 2022 | $994,000 | -13.8% | 1,069,000 | -7.4% | 0.00% | 0.0% |
Q1 2022 | $1,153,000 | +31.3% | 1,155,000 | +35.1% | 0.00% | – |
Q4 2021 | $878,000 | +6.8% | 855,000 | +7.5% | 0.00% | – |
Q3 2021 | $822,000 | -56.1% | 795,000 | -55.6% | 0.00% | -100.0% |
Q2 2021 | $1,872,000 | -82.7% | 1,792,000 | -81.4% | 0.00% | -83.3% |
Q4 2020 | $10,790,000 | +1.6% | 9,615,000 | -1.7% | 0.01% | -14.3% |
Q3 2020 | $10,620,000 | +13.6% | 9,786,000 | +1.8% | 0.01% | 0.0% |
Q2 2020 | $9,345,000 | +14.8% | 9,615,000 | -1.4% | 0.01% | 0.0% |
Q1 2020 | $8,141,000 | -12.1% | 9,749,000 | +1.4% | 0.01% | 0.0% |
Q4 2019 | $9,262,000 | +61646.7% | 9,615,000 | +53316.7% | 0.01% | – |
Q3 2019 | $15,000 | -94.6% | 18,000 | -93.8% | 0.00% | – |
Q2 2019 | $280,000 | +18.6% | 288,000 | +23.1% | 0.00% | – |
Q1 2019 | $236,000 | -64.8% | 234,000 | -75.1% | 0.00% | -100.0% |
Q4 2018 | $670,000 | -9.8% | 941,000 | +6.6% | 0.00% | 0.0% |
Q3 2018 | $743,000 | +6091.7% | 883,000 | +6692.3% | 0.00% | – |
Q1 2018 | $12,000 | – | 13,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |